Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Ambu pre-announces results for Q2 2019/20 with organic revenue growth of 24% and sales of 313,000 single-use endoscopes. On this basis, the guidance for organic revenue growth for the full year is...
-
The Malaysian authorities have granted Ambu – as a manufacturer of medical devices – exemption from the two-week movement control order that has been declared with effect from 18 March, 2020. The...
-
With the rise in Covid-19 cases, the Malaysian government has declared that the entire country will be on a movement control order starting 18 March, 2020 and expected to end on 31 March, 2020. Ambu...
-
Ambu announces capital increase. Attachment Company_Announcement_no. 6 2019_20 ...
-
Ambu begins the year with double-digit sales growth, and a good performance across all geographies. The expansion of the sales organization as well as the preparations for products to be launched...
-
Ambu meddeler kapitalforhøjelse. Vedhæftet fil Selskabsmeddelelse nr. 3 2019_20 ...
-
Ambu announces capital increase. Attachment Company Annoucement no.3 2019_20 ...
-
Ambu A/S meddeler i dag, at bestyrelsesformand Jens Bager har informeret bestyrelsen om, at han efter ni år ønsker at udtræde af bestyrelsen ved selskabets ordinære generalforsamling i december 2019. ...
-
Ambu A/S announces today that the chairman of the board of directors Jens Bager has informed the board of directors that after 9 years of service he wishes to resign from the board of directors. Jens...
-
Ambu er i 4. kvartal overgået til direkte salg af aScope i USA, og derfor ender den organiske vækst for hele året som planlagt på 4 pct. Vores pipeline af endoskoper til engangsbrug følger planen og...